Abstract
Familial hemiplegic migraine type 1 (FMH-1) is a rare form of migraine with aura, which is characterized by transient hemiparesis, sensory loss and visual disturbances. This monogenic disease shares many common features with classic migraine, suggesting a similar molecular pathophysiology. Migraine is triggered by activation and sensitization of the trigeminovascular system, specifically the trigeminal nociceptive afferents innervating the meninges. Aura migraine is associated with cortical spreading depression (CSD), which is a short-lasting intense wave of neuronal and glial cell depolarization that slowly progresses over the cortex and is followed by long-lasting neuronal activity depression.
Keywords: familial hemiplegic migraine type 1, P/Q-type channel, T666M channels, T-type Ca2+ channel, voltage-gated Ca2+ channels
Missense mutations affecting conserved amino acids in the ion-conducting subunit of the P/Q-type Ca2+ channel (CaV2.1α1) are responsible for FMH-1.3,5-7 These channels govern neurotransmitter release at synaptic terminals.8,9 FMH-1 is one of most extensively studied channelopathy and many research groups are interested in how the symptoms of this disease are related to the molecular mechanisms of channel dysfunction and its misregulation. To date, 21 mutations in CaV2.1α1 have been associated with FMH-1.6 The mutation most frequently reported is a Methionine-to-Threonine substitution at position 666 (T666M), which has been found in 19 of 39 studied families.10
FMH-1 mutations are thought to confer a gain-of-function phenotype on P/Q channels, because most of them induce a hyperpolarizing shift in channel activation. Moreover, at the single channel level, several FMH-1 mutations show increased open probability. However, there are some discrepancies in the results published to date.3,6,7,11
The results obtained from FMH-1 mutations in model systems in which the channels are overexpressed, such as heterologous systems or knock out neurons, are still a matter of debate. Therefore, to validate the use of CaV2.1−/− neurons, Tao et al.12 expressed R192Q FMH-1 mutant channels and observed a significant increase in current density compared with control conditions. Interestingly, a similar increase has been found in the R192Q knock in mouse,13 suggesting that the changes in current amplitude induced by the FHM-1 mutations may not be dependent on the expression system.
In a recent paper published in the Journal of Neurophysiology, Tao and coworkers12 reported the effects of the T666M FMH-1 mutation expressed in trigeminal ganglion neurons of the CaV2.1−/− mouse. They showed that there was no difference in the cell surface expression level between WT and T666M channels. However, there was a significant decrease in the current density of T666M compared with WT channels at almost all voltages tested. In spite of possible space-clamp deficiencies as indicated by differences between the reversal potential for the currents in the current-voltage (IV) curves, there was an evident loss-of-function of T666M with respect to WT channels.
Interestingly, the authors found that in WT- or T666M-transfected small trigeminal neurons, the expression of low threshold (T-type) channels was modified. They concluded that the presence of T666M channels significantly increases T-type current density and modifies the voltage dependence of current activation to more hyperpolarized voltages.
In my opinion, the results in this paper may have an alternative interpretation. Neurons from the CaV2.1−/− mouse transfected with the WT channel, present a significant decrease in T-type current density compared with neurons from WT animals. This implies that the presence of P/Q channels, somehow, inhibits T-type current. The comparison of current amplitude between EGFP- and WT-expressing CaV2.1−/− neurons revealed a drastic reduction of T-type currents in the latter, supporting this interpretation. Finally, CaV2.1−/− neurons expressing the T666M channel showed no differences in current amplitude compared with the CaV2.1−/− neurons expressing EGFP. Taken together, these results suggest that the T666M channels do not directly regulate T-type current, instead, the absence of WT channels leads to an increase in T-type current expression. Although the T666M mutation induces a loss-of-function phenotype, the increase in T-type current amplitude may result in an increase of neuron excitability which produces a gain-of-function in the neuronal circuit. This hypothesis is supported by measurements of rheobase, where T666M-transfected CaV2.1−/− neurons needed less current injection than CaV2.1−/− neurons expressing WT channels to generate an action potential.
In conclusion, the study by Tao and coworkers provides interesting insights in the understanding of the molecular mechanisms that potentially underlie FMH-1 disease. This paper supports the idea that not all FMH-1 channels mediate a gain-of-function phenotype and, the gain-of-function in neuronal excitability may be associated with an indirect increase in T-type current density. The mechanism whereby this occurs remains unknown and should be explored in more detail in order to determine the relationship between P/Q- and T- type channels in healthy subjects and subjects presenting FMH-1.
Acknowledgments
I am grateful to Dr Gerald W. Zamponi and Dr Ricardo Felix for all the comments, suggestions and corrections on the manuscript.
Footnotes
Previously published online: www.landesbioscience.com/journals/channels/article/22146
References
- 1.Rajakulendran S, Kaski D, Hanna MG. Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS. Nat Rev Neurol. 2012;8:86–96. doi: 10.1038/nrneurol.2011.228. [DOI] [PubMed] [Google Scholar]
- 2.Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain. 1994;117:199–210. doi: 10.1093/brain/117.1.199. [DOI] [PubMed] [Google Scholar]
- 3.Pietrobon D. Familial hemiplegic migraine. Neurotherapeutics. 2007;4:274–84. doi: 10.1016/j.nurt.2007.01.008. [DOI] [PubMed] [Google Scholar]
- 4.Pietrobon D, Striessnig J. Neurobiology of migraine. Nat Rev Neurosci. 2003;4:386–98. doi: 10.1038/nrn1102. [DOI] [PubMed] [Google Scholar]
- 5.Felix R. Calcium channelopathies. Neuromolecular Med. 2006;8:307–18. doi: 10.1385/NMM:8:3:307. [DOI] [PubMed] [Google Scholar]
- 6.Pietrobon D. CaV2.1 channelopathies. Pflugers Arch. 2010;460:375–93. doi: 10.1007/s00424-010-0802-8. [DOI] [PubMed] [Google Scholar]
- 7.Uchitel OD, Inchauspe CG, Urbano FJ, Di Guilmi MN. CaV2.1 voltage activated calcium channels and synaptic transmission in familial hemiplegic migraine pathogenesis. J Physiol Paris. 2012;106:12–22. doi: 10.1016/j.jphysparis.2011.10.004. [DOI] [PubMed] [Google Scholar]
- 8.Catterall WA. Voltage-gated calcium channels. Cold Spring Harb Perspect Biol. 2011;3:a003947. doi: 10.1101/cshperspect.a003947. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Gandini MA, Felix R. Functional interactions between voltage-gated Ca(2+) channels and Rab3-interacting molecules (RIMs): new insights into stimulus-secretion coupling. Biochim Biophys Acta. 2012;1818:551–8. doi: 10.1016/j.bbamem.2011.12.011. [DOI] [PubMed] [Google Scholar]
- 10.Kors EE, Haan J, Giffin NJ, Pazdera L, Schnittger C, Lennox GG, et al. Expanding the phenotypic spectrum of the CACNA1A gene T666M mutation: a description of 5 families with familial hemiplegic migraine. Arch Neurol. 2003;60:684–8. doi: 10.1001/archneur.60.5.684. [DOI] [PubMed] [Google Scholar]
- 11.Adams PJ, Snutch TP. Calcium channelopathies: voltage-gated calcium channels. Subcell Biochem. 2007;45:215–51. doi: 10.1007/978-1-4020-6191-2_8. [DOI] [PubMed] [Google Scholar]
- 12.Tao J, Liu P, Xiao Z, Zhao H, Gerber BR, Cao YQ. Effects of familial hemiplegic migraine type 1 mutation T666M on voltage-gated calcium channel activities in trigeminal ganglion neurons. J Neurophysiol. 2012;107:1666–80. doi: 10.1152/jn.00551.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.van den Maagdenberg AM, Pietrobon D, Pizzorusso T, Kaja S, Broos LA, Cesetti T, et al. A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron. 2004;41:701–10. doi: 10.1016/S0896-6273(04)00085-6. [DOI] [PubMed] [Google Scholar]
